Legal disputes between Pfizer Inc. and the governments of Poland and Romania over unused Covid-19 vaccine purchases are now affecting the funding of their respective air traffic agencies.

These disputes stem from procurement contracts for vaccines that remained unused. The financial strain from these legal battles is creating a ripple effect, diverting or restricting resources intended for aviation infrastructure.

This situation signals a rare instance where pharmaceutical litigation impacts national transportation funding. Investors should monitor how these legal liabilities affect the fiscal stability of Eastern European state-funded agencies and their ability to maintain critical air traffic services.